Skip to content
10-Q

Quarterly Report

CARGO Therapeutics, Inc.

0000950170-24-095427

← back to feed
Filed
Aug 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 8, 2024 45.9M sh
Current Liabilities Q2 2024 · Jun 30, 2024 $26.42M
Current Liabilities Q2 2024 · Dec 31, 2023 $21.16M
Total Liabilities Q2 2024 · Jun 30, 2024 $53.91M
Total Liabilities Q2 2024 · Dec 31, 2023 $47.65M
Current Assets Q2 2024 · Jun 30, 2024 $448.1M
Current Assets Q2 2024 · Dec 31, 2023 $409.48M
Total Assets Q2 2024 · Jun 30, 2024 $490.01M
Total Assets Q2 2024 · Dec 31, 2023 $453.04M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $405.73M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $42.37M
Shares Diluted Q2 2024 · Jun 30, 2023 672.25K sh
Shares Diluted Q2 2024 · Jun 30, 2023 634.7K sh
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$28.97M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$74.98M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$57.76M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$35.24M
Eps Diluted Q2 2024 · Jun 30, 2023 −$26.56
Eps Diluted Q2 2024 · Jun 30, 2023 −$48.21
Eps Basic Q2 2024 · Jun 30, 2023 −$26.56
Eps Basic Q2 2024 · Jun 30, 2023 −$48.21
Sga Expense Q2 2024 · Jun 30, 2023 $3.87M
Sga Expense Q2 2024 · Jun 30, 2023 $6.55M
Rd Expense Q2 2024 · Jun 30, 2023 $13.93M
Rd Expense Q2 2024 · Jun 30, 2023 $26.49M
Net Income Q2 2024 · Jun 30, 2023 −$17.85M
Net Income Q2 2024 · Jun 30, 2023 −$30.6M
Net Income Q2 2024 · Mar 31, 2023 −$12.75M
Operating Income Q2 2024 · Jun 30, 2023 −$17.8M
Operating Income Q2 2024 · Jun 30, 2023 −$33.04M